A 57-year-old man with symptoms and signs consistent with atypical pneumonia had epidemiologic and later serologic evidence of psittacosis pneumonia. Therapy with tetracycline resulted in rapid resolution.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Chlamydia psittaci pneumonia - evolutionary aspects on chest CT.
BMC Infect Dis
January 2025
Department of Radiology, The Affiliated Brain Hospital of Nanjing Medical University, No.264, Guangzhou Road, Gulou District, Nanjing, 210029, Jiangsu, China.
Purpose: To present the different findings of Chlamydia psittaci (C. psittaci) pneumonia on computed tomography (CT) according to the progression of the disease, to improve diagnostic accuracy, guide early clinical diagnosis, evaluate treatment efficacy, and reduce the mortality associated with the disease.
Methods: In total, 80 cases of C.
Psittacosis Pneumonia Features, Distinguishing Characteristics, and Outcomes: A Retrospective Study.
Infect Drug Resist
December 2024
Department of Infectious Diseases, Shaoxing People's Hospital, Shaoxing, Zhejiang, People's Republic of China.
Purpose: Psittacosis is an often-neglected cause of community acquired pneumonia (CAP). The limited diagnostic methods for psittacosis pneumonia invariably result in an unfavourable prognosis. Consequently, the early detection of psittacosis pneumonia is crucial.
View Article and Find Full Text PDFEarly and rapid diagnosis of pneumonia by tNGS in six patients: a case series.
Front Med (Lausanne)
November 2024
Department of Clinical Laboratory, Wuhan Asia General Hospital, Wuhan Asia General Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China.
Background: Psittacosis is a zoonotic infectious disease caused by () infection, which can be transmitted by birds, poultry and wild animals. The symptoms and imaging findings of pneumonia are atypical and primarily rely on etiological diagnosis. The incidence of infection has been significantly underestimated because of the low sensitivity and poor timeliness of traditional diagnostic methods.
View Article and Find Full Text PDFOmadacycline in the Treatment of Pneumonia: A Retrospective Study on Efficacy and Safety.
Br J Hosp Med (Lond)
November 2024
Department of Critical Care Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
is an obligate intracellular bacterium that primarily infects birds, but can cause respiratory infections in humans. Clinical evidence supporting the use of omadacycline for the treatment of pneumonia remains limited; therefore, this study aimed to evaluate the potential of omadacycline in treating pneumonia by analyzing the patients' clinical outcomes and the drug safety profile. We retrospectively reviewed the medical records of 15 patients with pneumonia treated at the First Affiliated Hospital, Zhejiang University School of Medicine between January and December 2023.
View Article and Find Full Text PDFDiagnosis and treatment experience of Chlamydia psittaci pneumonia: A multicenter retrospective study in China.
BMC Infect Dis
November 2024
Department of Respiratory and Critical Care, Emergency and Critical Care Medical Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Article Synopsis
- Chlamydia psittaci pneumonia cases are rising and can lead to severe respiratory issues, complicating diagnosis due to ineffective detection methods.
- A study of 61 pneumonia cases in China classified them into severe and non-severe groups to analyze differences in symptoms, lab results, and treatment.
- Results indicated fever as a key symptom, with elevated CRP and PCT levels being notable, while doxycycline is identified as the preferred treatment for severe cases.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!